Pandorum Technologies secures USD 11 million investment to advance its regenerative therapy for corneal blindness to clinical phase
Mar 15, 2024
Bengaluru (Karnataka) [India], March 15: Pandorum Technologies, a leading biotechnology company, announced today the successful closure of a pre-Series B funding round, securing USD 11 million (INR 88 crore) in investment. The funding was sourced from Mr. Ashish Kacholia, Everest Finance Investment, Acebright Pharma and Ms. Bandana Kankani's syndicate along with existing investors Mr. Sunil Kant Munjal and the Indian Angel Network.
Read More ..